{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:08:33Z","timestamp":1765357713487,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["21K16037"],"award-info":[{"award-number":["21K16037"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Landiolol, an ultra-short-acting \u03b21-selective blocker, is more effective in controlling heart rate compared with digoxin in patients with atrial tachyarrhythmias and left ventricular dysfunction. However, the effect of atrial tachyarrhythmia type on the effectiveness of landiolol remains unknown. Hence, this study aimed to evaluate the effectiveness of landiolol in patients with atrial fibrillation (AF) and atrial tachycardia (AT), not limited to those with heart failure with a reduced ejection fraction. To this end, we evaluated the efficacy and safety of landiolol in managing tachycardiac AF and tachycardiac atrial flutter\/AT in 44 patients with reduced left ventricular function. We found that while landiolol was effective in managing patients with AF and heart failure with a preserved or mid-range ejection fraction, however, it might be more challenging to control heart rate in patients with AT using a similar dosage of landiolol.<\/jats:p>","DOI":"10.3390\/medicina60111782","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T06:55:37Z","timestamp":1730357737000},"page":"1782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-5892","authenticated-orcid":false,"given":"Kengo","family":"Ayabe","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Miyazaki Medical Association Hospital, Miyazaki 880-2102, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2138-0084","authenticated-orcid":false,"given":"Tomoyoshi","family":"Komiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Tokai University School of Medicine, Isehara 259-1193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takekawa","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Miyazaki Medical Association Hospital, Miyazaki 880-2102, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6456-7358","authenticated-orcid":false,"given":"Honsa","family":"Kang","sequence":"additional","affiliation":[{"name":"Fukuoka City Hospital Cardiology Department, Fukuoka 812-0046, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Tsumagari","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Miyazaki Medical Association Hospital, Miyazaki 880-2102, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Ito","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Miyazaki Medical Association Hospital, Miyazaki 880-2102, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ashikaga","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Miyazaki Medical Association Hospital, Miyazaki 880-2102, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Miyazaki Medical Association Hospital, Miyazaki 880-2102, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1253\/circj.CJ-12-1618","article-title":"Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: Comparison of the ultra-short-acting \u03b21-selective blocker landiolol with digoxin (J-Land Study)","volume":"77","author":"Nagai","year":"2013","journal-title":"Circ. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00540-008-0640-4","article-title":"Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts","volume":"22","author":"Ikeshita","year":"2008","journal-title":"J. Anesth."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.joa.2015.09.002","article-title":"Practical applicability of landiolol, an ultra-short-acting \u03b21-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction","volume":"32","author":"Wada","year":"2016","journal-title":"J. Arrhyth."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","article-title":"Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease","volume":"64","author":"Andersson","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.90.4.2153","article-title":"Beta-blocker treatment for chronic heart failure. The frog prince","volume":"90","author":"Eichhorn","year":"1994","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Masarone, D., Martucci, M.L., Errigo, V., and Pacileo, G. (2021). The use of \u03b2-blockers in heart failure with reduced ejection fraction. J. Cardiovasc. Devel. Dis., 8.","DOI":"10.3390\/jcdd8090101"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"D11","DOI":"10.1093\/eurheartjsupp\/suac023","article-title":"Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure","volume":"24","author":"Shiga","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ayabe, K., Komiyama, T., Hasegawa, M., Sakai, T., Morise, M., Sakama, S., Yagishita, A., Amino, M., Ikari, Y., and Yoshioka, K. (2021). Clinical Significance of the Head-Up Tilt Test in Improving Prognosis in Patients with Possible Neurally Mediated Syncope. Biology, 10.","DOI":"10.3390\/biology10090919"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jacc.2019.03.478","article-title":"ACC\/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison","volume":"73","author":"Gaggin","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1253\/circj.CJ-18-1131","article-title":"Differential effectiveness of landiolol between atrial fibrillation and atrial flutter\/atrial tachycardia patients with left ventricular dysfunction","volume":"83","author":"Oka","year":"2019","journal-title":"Circ. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1053\/j.jvca.2019.11.003","article-title":"Cost-effectiveness analysis of landiolol, an ultrashort-acting beta-blocker, for prevention of postoperative atrial fibrillation for the Germany health care system","volume":"34","author":"Walter","year":"2020","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Shah","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1093\/eurheartj\/sux037","article-title":"Landiolol: Pharmacology and its use for rate control in atrial fibrillation in an emergency setting","volume":"20","author":"Domanovits","year":"2018","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1093\/eurheartjsupp\/suac024","article-title":"The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: Case reports and review of literature","volume":"24","author":"Bezati","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5492\/wjccm.v4.i3.251","article-title":"Landiolol, an ultra-short-acting \u03b21-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis","volume":"4","author":"Okajima","year":"2015","journal-title":"World J. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.15420\/aer.2020.34","article-title":"Frequency and determinants of spontaneous conversion to sinus rhythm in patients presenting to the emergency department with recent-onset atrial fibrillation: A systematic review","volume":"9","author":"Pluymaekers","year":"2020","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Levy, B., Slama, M., Lakbar, I., Maizel, J., Kato, H., Leone, M., and Okada, M. (2024). Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13102951"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","article-title":"Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(12)61463-9","article-title":"Catheter ablation of atrial arrhythmias: State of the art","volume":"380","author":"Lee","year":"2012","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Titus, A., Syeed, S., Baburaj, A., Bhanushali, K., Gaikwad, P., Sooraj, M., Saji, A.M., Mir, W.A.Y., Kumar, P.A., and Dasari, M. (2024). Catheter ablation versus medical therapy in atrial fibrillation: An umbrella review of meta-analyses of randomized clinical trials. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-023-03670-5"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCEP.111.967810","article-title":"Atrioventricular nodal ablation in atrial fibrillation: A meta-analysis and systematic review","volume":"5","author":"Chatterjee","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1540-8167.2008.01181.x","article-title":"Complications of catheter ablation for atrial fibrillation: Incidence and predictors","volume":"19","author":"Spragg","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:25:18Z","timestamp":1760113518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["medicina60111782"],"URL":"https:\/\/doi.org\/10.3390\/medicina60111782","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}